Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 16Phase 1 12Phase 1/2 10Phase 4 8Phase NA 7Phase 2/3 1

Status

Completed 4Recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 8

Sponsor

Cancer Type

Tumor-Agnostic 2Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 11Neoplasms 8Vomiting 6Nausea 5Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain, Postoperative 2Neoplasm, Residual 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms 2Wrist Fractures 1Systemic Inflammatory Response Syndrome 1Supratentorial Neoplasms 1Radicular Cyst 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Mediastinal Neoplasms 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Dexamethasone × Clear all
NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT06118710 2024-09-25

DEXASTOP

Erasmus Medical Center

Phase 4 Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT00588835 2020-11-30

ACE

Radboud University Medical Center

Phase 4 Terminated
20 enrolled

Nausea, Neoplasms

NCT02815319 2020-04-28

REaCT-dex

Ottawa Hospital Research Institute

Phase 4 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed
494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT02532634 2018-05-11

RAPA

Kangdong Sacred Heart Hospital

Phase 4 Completed
292 enrolled

Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Merck Sharp & Dohme LLC

Phase 4 Completed
118 enrolled

Nausea, Neoplasms, Vomiting

NCT03017391 2017-01-11

Treatment Algorithm for Nausea and Vomiting in the Palliative Phase

Radboud University Medical Center

Phase 4 Unknown
20 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡